{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:07:47Z","timestamp":1793678867638,"version":"4.5.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Clinical Research Plan of SHDC","award":["SHDC\u20112020CR1003A"],"award-info":[{"award-number":["SHDC\u20112020CR1003A"]}]},{"name":"the Key Disease Joint Research Program of Xuhui District","award":["XHLHGG202103"],"award-info":[{"award-number":["XHLHGG202103"]}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2019YFC1316000"],"award-info":[{"award-number":["2019YFC1316000"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972232"],"award-info":[{"award-number":["81972232"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Shanghai Municipal Natural Science Foundation","award":["20JC1419103"],"award-info":[{"award-number":["20JC1419103"]}]},{"name":"Beijing Mutual Care Public Welfare Foundation","award":["GDXZ-08-05"],"award-info":[{"award-number":["GDXZ-08-05"]}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["No. SZSM202003009"],"award-info":[{"award-number":["No. SZSM202003009"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202210246001S"],"award-info":[{"award-number":["202210246001S"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Perineural invasion (PNI) is associated with metastasis in malignancies, including intrahepatic cholangiocarcinoma (ICC), and is correlated with poor prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study included three large cohorts: ZS-ICC and TMA cohorts from our team, MSK cohort from a public database, and a small cohort named cohort 4. Prognostic implications of PNI were investigated in MSK cohort and TMA cohort. PNI-related genomic and transcriptomic profiles were analyzed in MSK and ZS-ICC cohorts. GO, KEGG, and ssGSEA analyses were performed. Immunohistochemistry was used to investigate the relationship between PNI and markers of neurons, hydrolases, and immune cells. The efficacy of adjuvant therapy in ICC patients with PNI was also assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 30.6% and 20.7% ICC patients had PNI in MSK and TMA cohorts respectively. Patients with PNI presented with malignant phenotypes such as high CA19-9, the large bile duct type, lymph node invasion, and shortened overall survival (OS) and relapse-free survival (RFS). Nerves involved in PNI positively express tyrosine hydroxylase (TH), a marker of sympathetic nerves. Patients with PNI showed high mutation frequency of KRAS and an immune suppressive metastasis prone niche of decreased NK cell, increased neutrophil, and elevated PD-L1, CD80, and CD86 expression. Patients with PNI had an extended OS after adjuvant therapy with TEGIO, GEMOX, or capecitabine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study deciphered the genomic features and the immune suppressive metastasis-prone niche in ICC with PNI. Patients with PNI showed a poor prognosis after surgery but a good response to adjuvant chemotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Graphical abstract<\/jats:title><\/jats:sec>","DOI":"10.1007\/s12072-022-10445-1","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:41:27Z","timestamp":1669300887000},"page":"63-76","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion"],"prefix":"10.1007","volume":"17","author":[{"given":"Xian-Long","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Ying","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Zi","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Man","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Huang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Bin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lv","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Wu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3817-9117","authenticated-orcid":false,"given":"Guo-Ming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"issue":"3","key":"10445_CR1","doi-asserted-by":"publisher","first-page":"107327481772924","DOI":"10.1177\/1073274817729245","volume":"24","author":"NN Massarweh","year":"2017","unstructured":"Massarweh NN, El-Serag HB. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control 2017;24(3):1073274817729245","journal-title":"Cancer Control"},{"issue":"5","key":"10445_CR2","doi-asserted-by":"publisher","first-page":"BSR20180044","DOI":"10.1042\/BSR20180044","volume":"38","author":"J Fu","year":"2018","unstructured":"Fu J, Li Y, Li Z, Li N. Clinical utility of decarboxylation prothrombin combined with \u03b1-fetoprotein for diagnosing primary hepatocellular carcinoma. Biosci Rep 2018;38(5):BSR20180044","journal-title":"Biosci Rep"},{"issue":"3","key":"10445_CR3","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/cancers2031513","volume":"2","author":"IE Demir","year":"2010","unstructured":"Demir IE, Ceyhan OG, Liebl F, et al. Neural invasion in pancreatic cancer: the past, present and future. Cancers (Basel) 2010;2(3):1513\u20131527","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10445_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrgastro.2015.166","volume":"12","author":"IE Demir","year":"2015","unstructured":"Demir IE, Friess H, Ceyhan GO. Neural plasticity in pancreatitis and pancreatic cancer. Nat Rev Gastroenterol Hepatol 2015;12(11):649\u2013659","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10445_CR5","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1158\/0008-5472.CAN-13-2050","volume":"74","author":"RE Stopczynski","year":"2014","unstructured":"Stopczynski RE, Normolle DP, Hartman DP, et al. Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma. Cancer Res 2014;74(6):1718\u20131727","journal-title":"Cancer Res"},{"issue":"10","key":"10445_CR6","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1158\/0008-5472.CAN-19-2689","volume":"80","author":"MW Yang","year":"2020","unstructured":"Yang MW, Tao LY, Jiang YS, et al. Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma. Cancer Res 2020;80(10):1991\u20132003","journal-title":"Cancer Res"},{"issue":"9","key":"10445_CR7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/jclinpath-2019-206372","volume":"73","author":"B Zhao","year":"2020","unstructured":"Zhao B, Lv W, Mei D, Luo R, et al. Perineural invasion as a predictive factor for survival outcome in gastric cancer patients: a systematic review and meta-analysis. J Clin Pathol 2020;73(9):544\u2013551","journal-title":"J Clin Pathol"},{"issue":"1","key":"10445_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00404-015-3627-z","volume":"292","author":"L Cui","year":"2015","unstructured":"Cui L, Shi Y, Zhang GN. Perineural invasion as a prognostic factor for cervical cancer: a systematic review and meta-analysis. Arch Gynecol Obstet 2015;292(1):13\u201319","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"10445_CR9","doi-asserted-by":"publisher","first-page":"E161","DOI":"10.1148\/rg.2021200222","volume":"41","author":"KS Madhusudhan","year":"2021","unstructured":"Madhusudhan KS. Perineural invasion in gallbladder cancer. Radiographics 2021; 41(5):E161-E162","journal-title":"Radiographics"},{"key":"10445_CR10","doi-asserted-by":"publisher","first-page":"12781","DOI":"10.1038\/s41598-021-92343-4","volume":"11","author":"P Narayan","year":"2021","unstructured":"Narayan P, et al. Perineural invasion as a risk factor for locoregional recurrence of invasive breast cancer. Sci Rep. 2021;11:12781. https:\/\/doi.org\/10.1038\/s41598-021-92343-4","journal-title":"Sci Rep"},{"issue":"3","key":"10445_CR11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.pathol.2017.09.013","volume":"50","author":"S Lubig","year":"2018","unstructured":"Lubig S, et al. Quantitative perineural invasion is a prognostic marker in prostate cancer. Pathology 2018;50(3):298\u2013304","journal-title":"Pathology"},{"issue":"4","key":"10445_CR12","first-page":"5839","volume":"8","author":"X Wang","year":"2015","unstructured":"Wang X, et al. Perineural invasion: a potential reason of hepatocellular carcinoma bone metastasis. Int J Clin Exp Med 2015;8(4):5839\u20135846","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10445_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12885-020-06781-w","volume":"20","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, et al. Perineural invasion as a prognostic factor for intrahepatic cholangiocarcinoma after curative resection and a potential indication for postoperative chemotherapy: a retrospective cohort study. BMC Cancer 2020;20(1):270","journal-title":"BMC Cancer"},{"issue":"5","key":"10445_CR14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41388-020-01578-4","volume":"40","author":"X Tan","year":"2021","unstructured":"Tan X, et al. Nerve fibers in the tumor microenvironment in neurotropic cancer-pancreatic cancer and cholangiocarcinoma. Oncogene 2021;40(5):899\u2013908","journal-title":"Oncogene"},{"key":"10445_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev-immunol-042718-041812","volume":"37","author":"C Godinho-Silva","year":"2019","unstructured":"Godinho-Silva C, Cardoso F, Veiga-Fernandes H. Neuro-immune cell units: a new paradigm in physiology. Annu Rev Immunol 2019;37:19\u201346","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10445_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","volume":"40","author":"L Dong","year":"2022","unstructured":"Dong L, et al. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma. Cancer Cell 2022;40(1):70-87.e15","journal-title":"Cancer Cell"},{"issue":"3","key":"10445_CR17","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/hep.31829","volume":"74","author":"T Boerner","year":"2021","unstructured":"Boerner T, et al. Genetic determinants of outcome in intrahepatic cholangiocarcinoma. Hepatology 2021;74(3):1429\u20131444","journal-title":"Hepatology"},{"key":"10445_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.705378","volume":"12","author":"XJ Guo","year":"2021","unstructured":"Guo XJ, et al. CTLA-4 synergizes with PD1\/PD-L1 in the inhibitory tumor microenvironment of intrahepatic cholangiocarcinoma. Front Immunol 2021;12: 705378","journal-title":"Front Immunol"},{"issue":"1","key":"10445_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/hep.23661","volume":"52","author":"GM Shi","year":"2010","unstructured":"Shi GM, et al. CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma. Hepatology 2010;52(1):183\u2013196","journal-title":"Hepatology"},{"issue":"21","key":"10445_CR20","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 2004;10(21):7252\u20137259","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10445_CR21","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","volume":"7","author":"YR Miao","year":"2022","unstructured":"Miao YR, Zhang Q, Lei Q, Luo M, Xie GY, Wang H, Guo AY. ImmuCellAI: a unique method for comprehensive T-Cell subsets abundance prediction and its application in cancer immunotherapy. Adv Sci 2020;7(7):1902880","journal-title":"Adv Sci"},{"issue":"7","key":"10445_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/bjs\/znac098","volume":"109","author":"T Wei","year":"2022","unstructured":"Wei T, et al. Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study. Br J Surg 2022;109(7):610\u2013616","journal-title":"Br J Surg"},{"issue":"3","key":"10445_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41568-019-0237-2","volume":"20","author":"AH Zahalka","year":"2020","unstructured":"Zahalka AH, Frenette PS. Nerves in cancer. Nat Rev Cancer 2020;20(3):143\u2013157","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10445_CR24","doi-asserted-by":"publisher","first-page":"R264","DOI":"10.1152\/ajpregu.00687.2009","volume":"300","author":"K Burgi","year":"2011","unstructured":"Burgi K, et al. Tyrosine hydroxylase immunoreactivity as indicator of sympathetic activity: simultaneous evaluation in different tissues of hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2011;300(2):R264\u2013R271","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"10445_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.pneurobio.2009.10.020","volume":"90","author":"IN Day","year":"2010","unstructured":"Day IN, Thompson RJ. UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein. Progress Neurobiol 2010;90(3):327\u2013362","journal-title":"Progress Neurobiol"},{"issue":"2","key":"10445_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gene.2015.03.061","volume":"563","author":"M Mariani","year":"2015","unstructured":"Mariani M, et al. Class III \u03b2-tubulin in normal and cancer tissues. Gene 2015;563(2):109\u2013114","journal-title":"Gene"},{"issue":"1","key":"10445_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1750-3639.1993.tb00729.x","volume":"3","author":"G Thiel","year":"1993","unstructured":"Thiel G. Synapsin I, synapsin II, and synaptophysin: marker proteins of synaptic vesicles. Brain Pathol (Zurich, Switzerland) 1993;3(1):87\u201395","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"issue":"4","key":"10445_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10158-020-00252-4","volume":"20","author":"E Ehrhardt","year":"2020","unstructured":"Ehrhardt E, Boyan G. Evidence for the cholinergic markers ChAT and vAChT in sensory cells of the developing antennal nervous system of the desert locust Schistocerca gregaria. Invertebr Neurosci 2020;20(4):19","journal-title":"Invertebr Neurosci"},{"issue":"6","key":"10445_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1192\/bjp.bp.110.086991","volume":"198","author":"DM Fergusson","year":"2011","unstructured":"Fergusson DM, Boden JM, Horwood LJ, Miller AL, Kennedy MA. MAOA, abuse exposure and antisocial behaviour: 30-year longitudinal study. Br J Psychiatry 2011;198(6):457\u2013463","journal-title":"Br J Psychiatry"},{"key":"10445_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1471-2350-12-74","volume":"12","author":"FW Lung","year":"2011","unstructured":"Lung FW, Tzeng DS, Huang MF, Lee MB. Association of the MAOA promoter uVNTR polymorphism with suicide attempts in patients with major depressive disorder. BMC Med Genet 2011;12:74","journal-title":"BMC Med Genet"},{"issue":"1","key":"10445_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jamasurg.2021.5679","volume":"157","author":"SL Zhou","year":"2022","unstructured":"Zhou SL, et al. Association of KRAS variant subtypes with survival and recurrence in patients with surgically treated intrahepatic cholangiocarcinoma. JAMA Surg 2022;157(1):59\u201365","journal-title":"JAMA Surg"},{"issue":"8","key":"10445_CR32","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/cac2.12188","volume":"41","author":"J Li","year":"2021","unstructured":"Li J, Kang R, Tang D. Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma. Cancer Commun (London, England). 2021;41(8):642\u2013660","journal-title":"Cancer Commun (London, England)."},{"issue":"8","key":"10445_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101117","volume":"14","author":"G Lopes-Santos","year":"2021","unstructured":"Lopes-Santos G, Bernab\u00e9 DG, Miyahara GI, Tjioe KC. Beta-adrenergic pathway activation enhances aggressiveness and inhibits stemness in head and neck cancer. Transl Oncol 2021;14(8): 101117","journal-title":"Transl Oncol"},{"key":"10445_CR34","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.2147\/OTT.S190847","volume":"12","author":"C Ma","year":"2019","unstructured":"Ma C, et al. Sympathetic innervation contributes to perineural invasion of salivary adenoid cystic carcinoma via the \u03b22-adrenergic receptor. Onco Targets Ther. 2019;12:1475\u20131495","journal-title":"Onco Targets Ther"},{"issue":"5","key":"10445_CR35","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-11-0641","volume":"18","author":"SW Cole","year":"2012","unstructured":"Cole SW, Sood AK. Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res 2012;18(5):1201\u20131206","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10445_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.18632\/aging.104204","volume":"13","author":"J Wang","year":"2020","unstructured":"Wang J, et al. ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration. Aging (Albany NY) 2020;13(1):351\u2013363","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"10445_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007311","volume":"14","author":"KS Lee","year":"2018","unstructured":"Lee KS, et al. Selection on the regulation of sympathetic nervous activity in humans and chimpanzees. PLoS Genet 2018;14(4): e1007311","journal-title":"PLoS Genet"},{"issue":"6","key":"10445_CR38","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jhep.2014.02.025","volume":"60","author":"J Li","year":"2014","unstructured":"Li J, et al. Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling. J Hepatol 2014;60(6):1225\u20131234","journal-title":"J Hepatol"},{"issue":"7","key":"10445_CR39","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/s41388-020-01615-2","volume":"40","author":"L Yin","year":"2021","unstructured":"Yin L, et al. MAOA promotes prostate cancer cell perineural invasion through SEMA3C\/PlexinA2\/NRP1-cMET signaling. Oncogene 2021;40(7):1362\u20131374","journal-title":"Oncogene"},{"key":"10445_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.710899","volume":"11","author":"D Sigorski","year":"2021","unstructured":"Sigorski D, Gulczy\u0144ski J, Sejda A, Rogowski W, I\u017cycka-\u015awieszewska E. Investigation of neural microenvironment in prostate cancer in context of neural density, perineural invasion, and neuroendocrine profile of tumors. Front Oncol 2021;11: 710899","journal-title":"Front Oncol"},{"issue":"5","key":"10445_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.smim.2014.01.003","volume":"26","author":"CJ Padro","year":"2014","unstructured":"Padro CJ, Sanders VM. Neuroendocrine regulation of inflammation. Semin Immunol 2014;26(5):357\u2013368","journal-title":"Semin Immunol"},{"issue":"3","key":"10445_CR42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000054276","volume":"8","author":"S Ben-Eliyahu","year":"2000","unstructured":"Ben-Eliyahu S, Shakhar G, Page GG, Stefanski V, Shakhar K. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. NeuroImmunoModulation 2000;8(3):154\u2013164","journal-title":"NeuroImmunoModulation"},{"issue":"1","key":"10445_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2003.11.075","volume":"357","author":"XH Jiang","year":"2004","unstructured":"Jiang XH, et al. Sympathetic nervous system mediates cold stress-induced suppression of natural killer cytotoxicity in rats. Neurosci Lett 2004;357(1):1\u20134","journal-title":"Neurosci Lett"},{"issue":"9","key":"10445_CR44","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","volume":"20","author":"S Jaillon","year":"2020","unstructured":"Jaillon S, et al. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer 2020;20(9):485\u2013503","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10445_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001946","volume":"9","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, et al. Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3. J Immunother Cancer 2021;9(3): e001946","journal-title":"J Immunother Cancer"},{"issue":"11","key":"10445_CR46","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/intimm\/dxaa025","volume":"32","author":"T Ao","year":"2020","unstructured":"Ao T, et al. Local sympathetic neurons promote neutrophil egress from the bone marrow at the onset of acute inflammation. Int Immunol 2020;32(11):727\u2013736","journal-title":"Int Immunol"},{"issue":"572","key":"10445_CR47","doi-asserted-by":"publisher","first-page":"eabb5817","DOI":"10.1126\/scitranslmed.abb5817","volume":"12","author":"M Perego","year":"2020","unstructured":"Perego M, et al. Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils. Sci Transl Med 2020;12(572):eabb5817","journal-title":"Sci Transl Med"},{"issue":"16","key":"10445_CR48","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.7150\/thno.36276","volume":"9","author":"JC Lu","year":"2019","unstructured":"Lu JC, et al. Distinct PD-L1\/PD1 profiles and clinical implications in intrahepatic cholangiocarcinoma patients with different risk factors. Theranostics 2019;9(16):4678\u20134687","journal-title":"Theranostics"},{"issue":"3","key":"10445_CR49","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1046\/j.1365-2567.1999.00888.x","volume":"98","author":"K Vandenborre","year":"1999","unstructured":"Vandenborre K, et al. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation. Immunology 1999;98(3):413\u2013421","journal-title":"Immunology"},{"issue":"12","key":"10445_CR50","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1002\/glia.22894","volume":"63","author":"A Louveau","year":"2015","unstructured":"Louveau A, et al. Targeting the CD80\/CD86 costimulatory pathway with CTLA4-Ig directs microglia toward a repair phenotype and promotes axonal outgrowth. Glia 2015;63(12):2298\u20132312","journal-title":"Glia"},{"issue":"Suppl 3","key":"10445_CR51","doi-asserted-by":"publisher","first-page":"S675","DOI":"10.1245\/s10434-012-2224-7","volume":"19","author":"TC Chen","year":"2012","unstructured":"Chen TC, Jan YY, Yeh TS. K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy. Ann Surg Oncol 2012;19(Suppl 3):S675\u2013S681","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10445_CR52","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s00432-020-03354-z","volume":"146","author":"Y Li","year":"2020","unstructured":"Li Y, et al. Preoperative prediction of perineural invasion and KRAS mutation in colon cancer using machine learning. J Cancer Res Clin Oncol 2020;146(12):3165\u20133174","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10445_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/humu.21377","volume":"32","author":"G Lothar","year":"2011","unstructured":"Lothar G, et al. Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders. Hum Mutat 2011;32(1):33\u201343","journal-title":"Hum Mutat"},{"key":"10445_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1476-4598-11-19","volume":"11","author":"DO Tiago","year":"2012","unstructured":"Tiago DO, et al. Syndecan-2 promotes perineural invasion and cooperates with K-ras to induce an invasive pancreatic cancer cell phenotype. Mol Cancer 2012;11:19","journal-title":"Mol Cancer"},{"issue":"14","key":"10445_CR55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12943-015-0462-6","volume":"14","author":"GZ Yu","year":"2015","unstructured":"Yu GZ, et al. PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma. Mol Cancer 2015;14(14):193","journal-title":"Mol Cancer"},{"issue":"2","key":"10445_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma\u2014evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 2018;15(2):95\u2013111","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10445_CR57","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1245\/s10434-016-5561-0","volume":"24","author":"JA Cienfuegos","year":"2017","unstructured":"Cienfuegos JA, et al. Perineural invasion is a major prognostic and predictive factor of response to adjuvant chemotherapy in stage I-II colon cancer. Ann Surg Oncol 2017;24(4):1077\u20131084","journal-title":"Ann Surg Oncol"},{"key":"10445_CR58","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.radonc.2019.01.002","volume":"133","author":"JH Song","year":"2019","unstructured":"Song JH, et al. Significance of perineural and lymphovascular invasion in locally advanced rectal cancer treated by preoperative chemoradiotherapy and radical surgery: can perineural invasion be an indication of adjuvant chemotherapy? Radiother Oncol 2019;133:125\u2013131","journal-title":"Radiother Oncol"},{"issue":"12","key":"10445_CR59","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/pros.23388","volume":"77","author":"G Sun","year":"2017","unstructured":"Sun G, et al. The impact of multifocal perineural invasion on biochemical recurrence and timing of adjuvant androgen-deprivation therapy in high-risk prostate cancer following radical prostatectomy. Prostate 2017;77(12):1279\u20131287","journal-title":"Prostate"},{"issue":"8","key":"10445_CR60","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/hed.25170","volume":"40","author":"D Nair","year":"2018","unstructured":"Nair D, et al. Perineural invasion: independent prognostic factor in oral cancer that warrants adjuvant treatment. Head Neck 2018;40(8):1780\u20131787","journal-title":"Head Neck"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10445-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10445-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10445-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T17:41:33Z","timestamp":1701452493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10445-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10445"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10445-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Xian-Long Meng, Jia-Cheng Lu, Hai-Ying Zeng, Zhen Chen, Xiao-Jun Guo, Chao Gao, Yan-Zi Pei, Shu-Yang Hu, Mu Ye, Qi-Man Sun, Guo-Huang Yang, Jia-Bin Cai, Pei-Xin Huang, Lei Yv, Lv Zhang, Ying-Hong Shi, Ai-Wu Ke, Jian Zhou, Jia Fan, Yi Chen, Xiao-Yong Huang, Guo-Ming Shi have declared that no competing interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Review Board of Zhongshan Hospital (Y2019-366), and all related procedures conformed to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}